Clinical Trial

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy and safety of KC1036 versus investigator's choice of chemotherapy in patients with advanced recurrent or metastatic esophageal squamous cell carcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-22.
Status change: Not Yet Recruiting → Recruiting 2024-03-06
Trial Details
NCT Number NCT06194734
Lead Sponsor Beijing Konruns Pharmaceutical Co., Ltd.
Conditions Esophageal Squamous Cell Carcinoma
Enrollment 490 participants
Start Date 2024-02-05
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-07